Critical points and potential pitfalls of outbreak of IMP-1-producing carbapenem-resistant Pseudomonas aeruginosa among kidney transplant recipients: a case–control study
Authors:
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 115, 83-92
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (402470/2018-4)
This publication has 26 references indexed in Scilit:
- Impact of Antibiotic Resistance on the Development of Recurrent and Relapsing Symptomatic Urinary Tract Infection in Kidney RecipientsAmerican Journal of Transplantation, 2015
- Extensively Drug-Resistant Pseudomonas aeruginosa Bacteremia in Solid Organ Transplant RecipientsTransplantation, 2015
- A Systematic Review and Meta-Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2014
- Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolatesDiagnostic Microbiology and Infectious Disease, 2014
- Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosaJournal of Medical Microbiology, 2013
- Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence typeClinical Microbiology and Infection, 2012
- Diagnostic accuracy of surveillance cultures to detect gastrointestinal colonization with multidrug-resistant gram-negative bacteriaAmerican Journal of Infection Control, 2012
- Swab cultures across three different body sites among carriers of carbapenem-resistant P. aeruginosa and Acinetobacter species: a poor surveillance strategyJournal of Hospital Infection, 2010
- Pseudomonas aeruginosa bacteremia over a 10‐year period: multidrug resistance and outcomes in transplant recipientsTransplant Infectious Disease, 2009
- Fluoroquinolone Enhances the Mutation Frequency for Meropenem-Selected Carbapenem Resistance in Pseudomonas aeruginosa , but Use of the High-Potency Drug Doripenem Inhibits Mutant FormationAntimicrobial Agents and Chemotherapy, 2008